cNPAS2 induced β cell dysfunction by regulating KANK1 expression in type 2 diabetes

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Genetics

Background:

• Type 2 Diabetes Mellitus (T2DM) affects over 400 million globally, characterized by impaired insulin secretion and insulin resistance.
• Understanding the molecular mechanisms of T2DM pathogenesis is crucial for developing effective interventions.

Purpose of the Study:

• To investigate the role of NPAS2 in T2DM pathogenesis.
• To explore NPAS2 as a diagnostic marker for T2DM.
• To evaluate the therapeutic potential of targeting NPAS2 and KANK1 in T2DM.

Main Methods:

• Gene expression analysis using RT-PCR and Western blot.
• Diagnostic marker evaluation via Receiver Operating Characteristic (ROC) curve analysis.
• Cell proliferation assays (CCK-8) and surgical intervention in T2DM mouse models (Roux-en-Y gastric bypass).

Main Results:

• NPAS2 was significantly upregulated in T2DM islet beta cells, correlating with apoptosis.
• NPAS2 demonstrated high diagnostic accuracy for T2DM.
• NPAS2 overexpression increased KANK1 levels; knockdown of NPAS2 and KANK1 enhanced MIN6 cell proliferation.
• Gastric bypass surgery reduced NPAS2 and KANK1 expression in T2DM mice.

Conclusions:

• NPAS2 induces beta cell dysfunction in T2DM by regulating KANK1 expression.
• NPAS2 represents a potential therapeutic target for T2DM.
• Gastric bypass may ameliorate T2DM by downregulating NPAS2 and KANK1.